Mark Corrao - Mar 4, 2025 Form 3 Insider Report for Apimeds Pharmaceuticals US, Inc. (APUS)

Role
Chief Financial Officer
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
Stock symbol
APUS
Transactions as of
Mar 4, 2025
Transactions value $
$0
Form type
3
Date filed
5/8/2025, 05:25 PM
Previous filing
Jan 10, 2022
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Corrao Mark Chief Financial Officer C/O APIMEDS PHARMACEUTICALS US, INC., 2 EAST BROAD STREET, 2ND FLOOR, HOPEWELL /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact 2025-05-08 0001634371

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney